Anhui (SZ:002983) Xin Lang Cai Jing·2025-11-28 02:43Core Viewpoint - The stock of Xinruida has shown a mixed performance in recent trading sessions, with a notable increase on November 28, 2023, and a year-to-date rise of 5.72% [1][2]. Group 1: Stock Performance - On November 28, 2023, Xinruida's stock price increased by 4.01%, reaching 20.50 CNY per share, with a trading volume of 17.96 million CNY and a turnover rate of 0.70% [1]. - Year-to-date, Xinruida's stock has risen by 5.72%, while it has increased by 7.72% over the last five trading days. However, it has seen a decline of 0.15% over the past 20 days and a more significant drop of 13.68% over the last 60 days [2]. Group 2: Company Overview - Xinruida Technology Co., Ltd. was established on May 15, 2012, and went public on April 28, 2020. The company is located in Hefei Economic and Technological Development Zone, Anhui Province [2]. - The main business areas of Xinruida include the research, design, production, sales, and technical services of new display optoelectronic systems and intelligent health light source systems. The revenue composition is as follows: display modules 88.12%, display terminals 10.24%, other 1.52%, and health intelligent light sources 0.13% [2]. Group 3: Financial Performance - For the period from January to September 2025, Xinruida reported a revenue of 733 million CNY, representing a year-on-year decrease of 4.11%. However, the net profit attributable to shareholders increased by 25.75% to 94.27 million CNY [2]. - Since its A-share listing, Xinruida has distributed a total of 246 million CNY in dividends, with 167 million CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, Xinruida had 21,300 shareholders, a decrease of 6.86% from the previous period, with an average of 6,008 circulating shares per shareholder, an increase of 7.36% [2]. - Among the top ten circulating shareholders, the new entrant is Baodao Jiuhang Mixed A (008318), holding 443,400 shares, while several other funds have exited the top ten list [3].